PRME Prime Medicine, Inc.

Ownership history in Alphabet Inc.  ·  13 quarters on record

This page tracks every 13F SEC filing in which Alphabet Inc. reported a position in Prime Medicine, Inc. (PRME). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
14.34% (2022 Q4)
Avg. % of fund
5.26%
First filed
2022 Q4
Last filed
2025 Q4
Quarters held
13
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 16,562,498 0% 2.23% $57.5M $3.47
2025 Q3 ADDED 16,562,498 +1,500,000 +10.0% 3.81% $91.8M $5.54
2025 Q2 UNCHANGED 15,062,498 0% 1.74% $37.2M $2.47
2025 Q1 UNCHANGED 15,062,498 0% 1.90% $30.0M $1.99
9 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PRME price (monthly, adj. close)
← Back to Alphabet Inc. Holdings